HCM
HUTCHMED (China) LtdMarquee-fund ownership over time
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Renaissance Technologies | Q3 2024(8Q snapshot) | 7Q | $20 | $12 | -40% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $19 | $12 | -37% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $19 | $12 | -37% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Two Sigma Investments | Q3 2024 | Q4 2025 | → $15 | -21% |
| D.E. Shaw 2× in & out | Q3 2025 | Q4 2025 | → $15 | -5% |
| Point72 Asset Management | Q3 2024 | Q4 2024 | → $17 | -12% |
| Bridgewater Associates | Q3 2019 | Q4 2023 | → $19 | -8% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at HUTCHMED (China) Ltd. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from May 21, 2026 — the most recent Form 4 on file — not from today.
Fundamentals
XBRL · HUTCHMED (China) LtdAnnual figures sourced directly from HUTCHMED (China) Ltd's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for HUTCHMED (China) Ltd — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 6-KInterim disclosure (foreign)Jun 5, 2026
- 6-KInterim disclosure (foreign)May 22, 2026
- 6-KInterim disclosure (foreign)May 21, 2026
- 6-KInterim disclosure (foreign)May 12, 2026
- 6-KInterim disclosure (foreign)Apr 30, 2026
- 6-KInterim disclosure (foreign)Apr 29, 2026
- 6-KInterim disclosure (foreign)Apr 9, 2026
- 6-KFORM 6-KApr 9, 2026
- 6-KInterim disclosure (foreign)Mar 23, 2026
- 6-KInterim disclosure (foreign)Mar 16, 2026
- 6-KInterim disclosure (foreign)Mar 11, 2026
- 6-KInterim disclosure (foreign)Mar 9, 2026
- 6-KInterim disclosure (foreign)Mar 6, 2026
- 6-KFORM 6-KMar 5, 2026
- 20-FAnnual report (foreign)Mar 5, 2026
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| D.E. Shaw | Q3 2025 | Q4 2025 | $16 | $15 | -5% |
| Citadel Advisors | Q3 2024 | open | $19 | $12 | -37% |
| Two Sigma Investments | Q3 2024 | Q4 2025 | $19 | $15 | -21% |
| D.E. Shaw | Q3 2024 | Q2 2025 | $19 | $13 | -32% |
| Millennium Management | Q3 2024 | open | $19 | $12 | -37% |
| Point72 Asset Management | Q3 2024 | Q4 2024 | $19 | $17 | -12% |
| Renaissance Technologies | Q3 2024 | open | $20 | $12 | -40% |
| Bridgewater Associates | Q3 2019 | Q4 2023 | $20 | $19 | -8% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.